Dvorák M, Kopecková P, Kopecek J
Departments of Pharmaceutics and Pharmaceutical Chemistry/CCCD, and of Bioengineering, University of Utah, Salt Lake City, UT 84112, USA.
J Control Release. 1999 Aug 5;60(2-3):321-32. doi: 10.1016/s0168-3659(99)00087-5.
High-molecular weight (branched) water-soluble N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers containing lysosomally degradable oligopeptide crosslinks were synthesized by radical copolymerization of HPMA and newly designed crosslinking agents, N(2), N(5)-bis(N-methacryloylglycylphenylalanylleucylglycyl)ornithine s with different modification of the carboxy group. The length of the primary chain was controlled by the addition of a chain transfer agent, 3-mercaptopropionic acid. A polymerizable derivative of the anticancer drug adriamycin (ADR), N-methacryloylglycylphenylalanylleucylglycyl adriamycin, was added to some polymerization mixtures. This resulted in high-molecular weight, branched, water-soluble HPMA copolymers containing oligopeptide sequences in the crosslinks as well as in side-chains terminated in ADR. The degradability of the crosslinks as well as the release of ADR by lysosomal enzymes isolated from rat liver were investigated.
通过甲基丙烯酸 - N -(2 - 羟丙基)酯(HPMA)与新设计的交联剂N(2), N(5)-双(N - 甲基丙烯酰甘氨酰苯丙氨酰亮氨酰甘氨酰)鸟氨酸(其羧基有不同修饰)进行自由基共聚反应,合成了含有可被溶酶体降解的寡肽交联键的高分子量(支链型)水溶性HPMA共聚物。通过添加链转移剂3 - 巯基丙酸来控制主链长度。将抗癌药物阿霉素(ADR)的可聚合衍生物N - 甲基丙烯酰甘氨酰苯丙氨酰亮氨酰甘氨酰阿霉素添加到一些聚合混合物中。这就得到了高分子量、支链型、水溶性的HPMA共聚物,其交联键中含有寡肽序列,且侧链末端为ADR。研究了交联键的降解性以及从大鼠肝脏分离得到的溶酶体酶对ADR的释放情况。